MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 259 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $309,232 | +3949.7% | 1,158 | +3409.1% | 0.00% | – |
Q4 2023 | $7,636 | -99.0% | 33 | -99.7% | 0.00% | -100.0% |
Q2 2022 | $739,000 | +19.2% | 10,327 | +62.3% | 0.01% | -28.6% |
Q2 2021 | $620,000 | +36.3% | 6,364 | +63.6% | 0.01% | 0.0% |
Q1 2021 | $455,000 | -46.0% | 3,891 | -45.1% | 0.01% | -41.7% |
Q3 2020 | $842,000 | +301.0% | 7,093 | +283.4% | 0.01% | +300.0% |
Q2 2020 | $210,000 | – | 1,850 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |